Viatris

Viatris

Yahoo Finance • 20 days ago

Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia

Opus Genetics, Inc. FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults in the United States Approval supported by positive results from p... Full story

Yahoo Finance • 25 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 28 days ago

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.6% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Stock index futures tick higher ahead of jobs report

[Wall Street Tumbles After Chinese Stocks Plunge 9 Percent] Stephen Chernin Stock index futures rose before the bell as investors braced for the September nonfarm payrolls report, with economic data resilience remaining a key driver of ma... Full story

Yahoo Finance • last month

Viatris sues Novo Nordisk over generic Wegovy patent dispute

Investing.com -- Viatris filed a lawsuit against Novo Nordisk in Delaware federal court, requesting a determination that its planned generic version of Wegovy would not violate the Danish company's patent rights. Still guessing which name... Full story

Yahoo Finance • 2 months ago

Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whi... Full story

Yahoo Finance • 2 months ago

Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks

The recent breakout of Moderna reminded investors that AI stocks aren't the only destination to make money. Healthcare and biotech stocks offer promising long-term opportunities if chosen wisely. We ran an analysis based on Insider Monkey... Full story

Yahoo Finance • 3 months ago

3 S&P 500 Stocks We Keep Off Our Radar

3 S&P 500 Stocks We Keep Off Our Radar The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether it's stagnating growth,... Full story

Yahoo Finance • 3 months ago

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sec... Full story

Yahoo Finance • 3 months ago

Viatris (VTRS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, August 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS CEO - Scott SmithInterim CFO - Paul CampbellChief R&D Officer - Philippe MartinChief Commercial Officer - Corinne Le GoffHead of Capital Mar... Full story

Yahoo Finance • 3 months ago

Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The latest research on Viatris centers on a revised price target of US$22 per share and what tha... Full story

Yahoo Finance • 3 months ago

Earnings scorecard: eight out of nine healthcare companies deliver EPS wins this week

Healthcare stocks (XLV [https://seekingalpha.com/symbol/XLV]) grabbed the spotlight this week as Wall Street digested earnings reports from companies including Centene (CNC [https://seekingalpha.com/symbol/CNC]), DexCom (DXCM [https://seek... Full story

Yahoo Finance • 3 months ago

3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and th... Full story

Yahoo Finance • 3 months ago

Stock index futures edge higher as investors seek rebound after Thursday selloff

[Wall Street New York stock exchange stock market] alexsl Stock index futures were higher on Friday as the stock market hoped to recover from Thursday's selloff. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) +0.33%, S&P 500... Full story

Yahoo Finance • 4 months ago

Financial Stocks Rally To New Highs. JPMorgan Is One Of Them.

JPMorgan Chase stock and two other financial names hit new highs. A pharmaceutical stock also reached a high and is in a buy zone. Continue Reading... Full story

Yahoo Finance • 4 months ago

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Choosing between Novartis AG (NYSE:NVS) and Teva Pharmaceutical Industries (NYSE:TEVA) requires weighing the stability of an established innovator against the potential of a generic specialist undergoing a significant turnaround. Novartis... Full story

Yahoo Finance • 4 months ago

3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Quick Read Pfizer's 7% yield and forward P/E of 8 complement Viatris's three FDA PDUFA decisions arriving before year-end 2026. Kimberly-Clark's pending acquisition of Kenvue at $3.50 cash plus shares gives holders a defined takeout floor... Full story

Yahoo Finance • 4 months ago

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Key Points Eli Lilly and dominance in weight loss and diabetes treatments continues to fuel massive revenue growth. Teva Pharmaceutical Industries offers a value-oriented play as it moves past legal hurdles and expands its biosimilar port... Full story

Yahoo Finance • 4 months ago

Viatris (VTRS) Secures Loan Amid Positive Phase 3 Results

Viatris Inc. (NASDAQ:VTRS) is one of the Top 10 Extreme Value Stocks To Buy Now. On July 1, Viatris Inc. (NASDAQ:VTRS) entered into a loan agreement with a group of lenders led by Mizuho Bank. The company secured a ¥40 billion senior unsec... Full story

Yahoo Finance • 4 months ago

ISCV vs. IWN: Which Small-Cap Value ETF Is the Better Buy?

While both funds target smaller U.S. companies that appear undervalued relative to the broader market, the iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) provides that exposure to the small-cap value space at a lower cost than the... Full story